 Editas Medicine Inc NASDAQ: EDIT announced data on a new gene-editing technology termed SLEEK SeLection by Essential-gene Exon Knock-in. Data were presented at the Cold Spring Harbor Laboratorys Genome Engineering: CRISPR Frontiers meeting. 